4 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Terminated 4 |
Follow Phobia, Social: new trials by email Literature Review of Phobia, Social trials Research Report on Phobia, Social
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder botulinum toxin A, Placebo - Anxiety Disorder Social, Anxiety | Phase 4 | Terminated | Daniel Lieberman | 4 | 2017-02-01 | 2019-01-23 |
| Brief Intervention to Reduce Fear of Public Speaking propranolol, Placebo - Social Anxiety Disorder | Phase 4 | Terminated | New York State Psychiatric Institute | 6 | 2016-06-01 | 2023-06-07 |
| Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP) Topiramate, Placebo - Social Phobia | Phase 4 | Terminated | McMaster University | 12 | 2004-03-01 | 2020-09-02 |
| Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders Sertraline, Placebo - Phobia, Social, Panic Disorder | Phase 4 | Terminated | Hamilton Health Sciences Corporation | 170 | 2002-07-01 | 2018-03-22 |
Anxiety Disorders (2) · Agoraphobia (1) · Depressive Disorder, Major (1) · Dysthymic Disorder (1) · Obsessive-Compulsive Disorder (1) · Panic Disorder (1)
Mental Disorders (4) · Phobic Disorders (4) · Anxiety Disorders (2) · Depressive Disorder (1) · Mood Disorders (1)
Botulinum Toxins, Type A (1) · Propranolol (1) · Sertraline (1) · Sodium Chloride (1) · Topiramate (1) · propranolol CR (1)
Daniel Lieberman (1) · Hamilton Health Sciences Corporation (1) · McMaster University (1) · New York State Psychiatric Institute (1)
Canada (2) · United States (2)
Michael Van Ameringen, MD, FRCPC (2) · Daniel Z Lieberman, MD (1) · Franklin Schneier, MD (1)